Navigation Links
Vestaron Corporation Announces New Leadership
Date:4/28/2011

KALAMAZOO, Mich., April 28, 2011 /PRNewswire/ -- Vestaron Corporation, a Kalamazoo-based company developing the next- generation of environmentally conscious insecticide products, announced today that John Sorenson, Ph.D., will serve as interim President and Chief Executive Officer. The Board of Directors thanks John McIntyre for his years of service leading to the development of breakthrough insecticides for agriculture.

"John's scientific leadership has been just what Vestaron needed to get us to where we are today," said Jim Schultz of Open Prairie Ventures, a major investor and board director. "We wish John well in his next endeavor."

John Sorenson, Ph.D., will serve as interim President and CEO and continue his current role as Chairman of the Board of Directors. Elin Miller will continue her role as Vice Chairman while the company searches for a new CEO. Vestaron has engaged Kincannon & Reed for the search, which has already begun.

"This is a critical and exciting time for our company with upcoming field trials this summer, which will set the stage for our registration submission. I am thrilled to take the helm," said Dr. Sorenson. Dr. Sorenson has a broad background in plant biotechnology, both in academe and in the private sector. In addition to serving as President of Biotechnology for Syngenta, he also served as President of Syngenta Seed, Inc. and held several positions in the Asgrow Seed Company. Sorenson began his career as Assistant and Associate Professor of Genetics at North Carolina State University.

Vestaron Corporation is a Kalamazoo, Mich.-based company that has been working for the past few years to develop insecticide products that are harmless to humans and other mammals and are environmentally conscious. Using the polypeptides found in spider venom, Vestaron which was formerly known as Venomix, Inc., has reported that its tests are seeing positive results against mosquitoes, caterpillars, flies and cockroaches.

Vestaron Corporation is a portfolio company of Open Prairie Ventures, an Effingham, Illinois- based venture capital firm with offices in Kalamazoo and Southwest Michigan First Life Science Fund.


'/>"/>
SOURCE Vestaron Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Mitsubishi Chemical Corporation Signs Memorandum of Understanding for Strategic Partnership With Genomatica for Sustainable Chemicals in Asia
2. Every Day is Earth Day for Yulex Corporation
3. Veteran Wall Street Securities Analyst Reports on Health Discovery Corporation
4. CryoLife Amends Tender Offer Related to its Proposed Acquisition of Cardiogenesis Corporation
5. delSECUR CORPORATION Announces Its Dissolution; and the Distribution of Its Asset to Its Lenders and Shareholders of the Corporation
6. Techne Corporation Announces Acquisition
7. Ther-Rx Corporation Commits to Take Action Regarding Makena™ Pricing
8. SARcode Corporation to Present Phase 2 Clinical Data for Dry Eye Candidate at the ARVO2011 Annual Meeting
9. United Therapeutics Corporation Completes Enrollment of FREEDOM-C(2) Trial
10. Volcano Corporation Presentation at Roth Capital Conference to be Webcast
11. Sanford Rose Associates® - Minneapolis Fills Key Management Position for the Micromedics Operation of Nordson Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... Sciences today announced the three Winners and six Finalists of the 2017 Blavatnik ... annually by the Blavatnik Family Foundation and administered by the New York Academy ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... genomics analysis platform specifically designed for life science researchers to analyze and ... researcher Rosalind Franklin, who made a major contribution to the discovery of ...
(Date:10/11/2017)... ... October 11, 2017 , ... Proscia ... be hosting a Webinar titled, “Pathology is going digital. Is your lab ready?” ... pathology adoption best practices and how Proscia improves lab economics and realizes an ...
(Date:10/11/2017)... Florida (PRWEB) , ... October 11, 2017 , ... ... Drug Administration (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 ... for the treatment of osteosarcoma. SBT-100 is able to cross the cell membrane ...
Breaking Biology Technology:
(Date:4/18/2017)... -- Socionext Inc., a global expert in SoC-based imaging and computing solutions, ... which features the company,s hybrid codec technology. A demonstration utilizing TeraFaces ... will be showcased during the upcoming Medtec Japan at Tokyo Big ... Las Vegas Convention Center April 24-27. ... Click here for an image of ...
(Date:4/13/2017)... 13, 2017 UBM,s Advanced Design and Manufacturing ... feature emerging and evolving technology through its 3D Printing ... run alongside the expo portion of the event and ... demonstrations focused on trending topics within 3D printing and ... manufacturing event will take place June 13-15, 2017 at the ...
(Date:4/11/2017)... 11, 2017 Crossmatch®, a globally-recognized leader ... today announced that it has been awarded a ... Activity (IARPA) to develop next-generation Presentation Attack Detection ... "Innovation has been a driving force within Crossmatch ... allow us to innovate and develop new technologies ...
Breaking Biology News(10 mins):